Zorro
PrivateLast Round
Series A
Jun 11, 2025
Total Funding Raised
$31.5M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Zorro operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Series A round in June 2025.
Zorro is a healthcare technology company that provides an AI-powered platform leveraging Individual Coverage Health Reimbursement Arrangements (ICHRA) to enable employers to offer personalized and cost-effective health benefits.
Sector
Healthcare & Life Sciences
Verticals
InsurTech, HR, Compliance
Business Model
B2B
Customer Profile
Subscription SaaS, Marketplace Commission
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Zorro Comparables
Compare Zorro with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BenefitBay | 94% | |
| Thatch | 93% | |
| Venteur | 91% |
For institutional investors. Book with your work email.
Zorro Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 11, 2025 | ||||
| Seed | Mar 28, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Zorro Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Entrée Capital | Series A |
| Entrée Capital | Series A |
| 10D | Series A, Seed |
| Pitango Venture Capital | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 157% MoM.
- Mar 1, 2026
Network includes over 120 carrier partners.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesAug 19, 2026
On Aug 19th '26 in New York, Zorro launches Ori, a conversational AI co-pilot that uses real-time recommendations to help employees select personalized ICHRA benefits plans.
- launchesAug 19, 2026
Zorro launches its overhauled Personalized Benefits Navigator in New York on Aug 19th '26, introducing Ori, a conversational AI consultant that provides real-time plan recommendations and combines AI with human guidance to simplify ICHRA enrollment.
- launchesAug 19, 2026
Zorro now offers a comprehensive concierge service model for companies with 250 employees or more, including dedicated service teams, bespoke onboarding, proactive monitoring and onsite enrollment services, in Aug '26.
For institutional investors. Book with your work email.
Zorro Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Zorro's valuation, stock price, and market status.
Is Zorro a public or private company?
Zorro is a private company.
What is the current stock price of Zorro?
Zorro is a private company, so its shares have no public market price. Caplight tracks Zorro's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Zorro worth (valuation)?
Valuation information for Zorro is not publicly available.
Can I buy Zorro stock?
Zorro shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Zorro's last funding round?
Zorro's most recent funding round was Series A on June 11, 2025.
Who are the main investors in Zorro?
Key investors in Zorro include Entrée Capital, Entrée Capital, 10D, Pitango Venture Capital.
Will Zorro IPO soon?
No public IPO plans have been announced for Zorro.
How can I track Zorro secondary market activity?
Caplight tracks bids, offers, and trades in Zorro's shares on secondary markets.